EAM
TEVA icon

Edge Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Edge Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$29.2M Sell
908,603
-759,647
-46% -$25.9M 0.22% 138
2016
Q4 		$60.5M Buy
1,668,250
+99,879
+6% +$3.99M 0.47% 77
2016
Q3 		$72.2M Buy
1,568,371
+299,924
+24% +$15.6M 0.6% 51
2016
Q2 		$63.7M Buy
1,268,447
+6,207
+0.5% +$330K 0.57% 56
2016
Q1 		$67.5M Sell
1,262,240
-35,318
-3% -$2.07M 0.65% 53
2015
Q4 		$85.2M Buy
1,297,558
+27,716
+2% +$1.71M 0.83% 38
2015
Q3 		$71.7M Sell
1,269,842
-367,136
-22% -$23.8M 0.72% 46
2015
Q2 		$96.7M Sell
1,636,978
-188,731
-10% -$11.6M 0.88% 35
2015
Q1 		$114M Buy
1,825,709
+11,591
+0.6% +$674K 0.99% 25
2014
Q4 		$104M Sell
1,814,118
-42,090
-2% -$2.34M 1.01% 27
2014
Q3 		$99.8M Buy
1,856,208
+23,600
+1% +$1.25M 1% 28
2014
Q2 		$96.1M Sell
1,832,608
-74,243
-4% -$3.79M 0.96% 29
2014
Q1 		$101M Sell
1,906,851
-317,341
-14% -$14.7M 1.07% 25
2013
Q4 		$89.1M Sell
2,224,192
-1,266,084
-36% -$49.9M 0.97% 28
2013
Q3 		$135M Buy
3,490,276
+1,593,333
+84% +$62.2M 0.82% 43
2013
Q2 		$74.4M Buy
+1,896,943
New +$73.9M 0.93% 36

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Edge Asset Management's TEVA Position: Q1 2017 in Review

Edge Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 46% in Q1 2017, selling an estimated $25.9M and leaving 908,603 shares worth $29.2M. The position accounts for 0.22% of the portfolio, ranked #138.

Edge Asset Management first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $135M in Q3 2013. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Edge Asset Management held 908,603 shares of Teva Pharmaceuticals worth $29.2M as of Q1 2017.
  • Edge Asset Management sold 759,647 Teva Pharmaceuticals shares in Q1 2017, an estimated $25.9M.
  • Teva Pharmaceuticals made up 0.22% of Edge Asset Management's portfolio in Q1 2017, its #138 holding.
  • Edge Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Edge Asset Management's Teva Pharmaceuticals position peaked at $135M in Q3 2013.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.